Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab - Bressler NM, Chang TS, Varma R, Suñer I, Lee P, Dolan CM, Ward J, Ianchulev T, Fine J.

OBJECTIVES: To determine the impact of ranibizumab on driving status, driving ability perception, and having 20/40 vision or better in patients with choroidal neovascularization resulting from age-related macular degeneration (AMD). DESIGN: Phase III, mult...
Source: SafetyLit: All (Unduplicated) - Category: Global & Universal Tags: Age: Elder Adults Source Type: news